Default company panoramic image
Logo

Cokiya Incorporated

Cokiya develops low-cost, high-performance surgical probes for improving radio-guided sentinel node biopsy and parathyroid localization.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Poway, CA, USA
  • Currency USD
  • Founded May 2013
  • Employees 3
  • Website cokiyainc.com

Company Summary

Cokiya is developing the first disposible gamma probe to address 400,000 radio-guided surgical procedures per year (US). This probe is comprised of proprietary microelectronics and photonics that enable industry leading performance at a tiny fraction of the cost of durable probes. It's advanced features will enable surgeons to optimize hotspot localization, with faster procedures, less dissection, and higher diagnostic accuracy.

Team

  • Default avatar
    Rick Conwell
    CEO
    Unconfirmed

    Medical and hi-tech product development, commercialization, general management. Co-founder of GammaMetrics (acquired), raised Digirad venture capital.

  • Default avatar
    Steve Yarnall
    COO
    Unconfirmed

    Med-tech recon, development, commercialization. Co-founder of Naviscan; also with Ethicon/Biopsys Medical (acquired), Elan/Dura Pharm (acquired), Puritan Bennett, Digirad.

  • Default avatar
    Joel Kindem, PhD
    CTO
    Unconfirmed

    Solid-state nuclear detector development, EE, ME, S/W product engineering. Brookhaven National Lab, Digirad, consultant to Lawrence Livermore National Lab.

Advisors

  • Default avatar
    Ilan Lovinsky, Gunderson Dettmer
    Lawyer
    Unconfirmed
    Default avatar
    Nancy Rix, Dickerson Rix, LLC
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Private Individuals
    Unconfirmed